All RISE data use requests will be reviewed by ACR staff and the ACR’s RISE Research and Publications Subcommittee. The process varies slightly based on whether or not the request is intended for publication. Once your request is received, it will go through the following process:
First, ACR staff will review the request to make an initial determination of whether it is feasible and whether it competes with any other requests that are ongoing or have been submitted in the last 24 months.
After administrative review, the request will be scheduled for review by the RISE Research and Publications Subcommittee.
The RISE Research and Publications Subcommittee will review requests based on the following criteria:
- The request is feasible given the data available in RISE.
- The request and study design are in accordance with the relevant guidance provided in the AMA's Code of Medical Ethics.
- The research topic is not too similar to an ongoing RISE data request or one made within the last 24 months.
After the subcommittee has reviewed the request, ACR staff will contact requestors with the results of the review.
Important Information
If you are interested in using RISE data as part of a grant, your request must be approved by the subcommittee before the grant application is submitted. In order to receive the review results before your grant application deadline, you must submit your data use request by the following deadlines.
Request submission deadline: July 10, 2018
Notifications sent: September 4, 2018
Request submission deadline: November 6, 2018
Notifications sent: January 7, 2019
Request submission deadline: March 6, 2019
Notifications sent: May 1, 2019
Request submission deadline: April 8, 2019
Notifications sent: June 3, 2019
If you need approval of your request by an upcoming notification date but missed the submission deadline, you can still submit your request and contact RISE@rheumatology.org with your application deadline. However, there is no guarantee that your request will be reviewed during the current review cycle.